The PE ratio for Bio-Rad Laboratories stock stands at 23.17 as of Aug 12, 2025. This takes into account the latest EPS of $11.86 and stock price of $274.76.
Over the last ten years, the average PE ratio of Bio-Rad Laboratories has been 66.03. The current 23.17 P/E ratio is 65% lower than the historical average. Looking back at the last ten years, BIO's PE ratio peaked in the Jun 2017 quarter at 514.34, with a price of $226.31 and an EPS of $0.44. The Sep 2021 quarter marked the lowest point at 3.34, with a price of $745.95 and an EPS of $223.61.
Maximum annual increase: 458.78% in 2016
Maximum annual decrease: -72.03% in 2017
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | N/A | N/A | $328.51 | -$65.36 |
2023 | N/A | N/A | $322.89 | -$21.82 |
2022 | N/A | N/A | $420.49 | -$121.79 |
2021 | 5.3 | 16.48% | $755.57 | $142.61 |
2020 | 4.55 | -27.55% | $582.94 | $128.13 |
2019 | 6.28 | -66.88% | $370.03 | $58.93 |
2018 | 18.96 | -67.27% | $232.22 | $12.25 |
2017 | 57.93 | -72.03% | $238.67 | $4.12 |
2016 | 207.14 | 458.78% | $182.28 | $0.88 |
2015 | 37.07 | -5.29% | $138.66 | $3.74 |
2014 | 39.14 | -13.86% | $120.56 | $3.08 |
2013 | 45.44 | 153.01% | $123.61 | $2.72 |
2012 | 17.96 | 19.49% | $105.05 | $5.85 |
2011 | 15.03 | -3.03% | $96.04 | $6.39 |
2010 | 15.5 | -15.16% | $103.85 | $6.7 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Jun 2025 | 20.35 | N/A | $241.32 | $11.86 |
Mar 2025 | N/A | N/A | $243.56 | -$76.07 |
Dec 2024 | N/A | N/A | $328.51 | -$65.36 |
Sep 2024 | N/A | N/A | $334.58 | -$27.62 |
Jun 2024 | N/A | N/A | $273.11 | -$47.34 |
Mar 2024 | N/A | N/A | $345.87 | -$10.67 |
Dec 2023 | N/A | N/A | $322.89 | -$21.82 |
Sep 2023 | N/A | N/A | $358.45 | -$5.99 |
Jun 2023 | N/A | N/A | $379.12 | -$15.12 |
Mar 2023 | N/A | N/A | $479.02 | -$6.58 |
Dec 2022 | N/A | N/A | $420.49 | -$121.79 |
Sep 2022 | N/A | N/A | $417.14 | -$201.71 |
Jun 2022 | N/A | N/A | $495 | -$64.48 |
Mar 2022 | N/A | N/A | $563.23 | -$2.72 |
Dec 2021 | 5.3 | 58.68% | $755.57 | $142.61 |
Currently, BIO's PE ratio is higher than its 5-year average, but it is lower than its 10-year average.
BIO's PE ratio stands lower than its peer stocks GE and TMO, but it is higher than JNJ's. Bio-Rad Laboratories's current PE ratio of 23.17 is lower than the average of its peers, which is 32.06.
Stock name | PE ratio | Market cap |
---|---|---|
JNJ Johnson & Johnson | 18.52 | $419.6B |
BIO Bio-Rad Laboratories Inc | 24.05 | $7.72B |
TMO Thermo Fisher Scientific Inc | 27.99 | $183.07B |
A Agilent Technologies Inc | 29.43 | $34.02B |
BDX Becton Dickinson & Co | 35.45 | $55.88B |
GE General Electric Co | 37.07 | $284.25B |
DHR Danaher Corp | 43.95 | $148.84B |
HBIO Harvard Bioscience Inc | N/A | $21.95M |
The price to earnings ratio for BIO stock is 23.17 as of Aug 12, 2025.
As an average over the last 5 years, BIO stock has a PE ratio of 6.68.
The highest quarterly PE ratio in the last ten years has been 514.34 and it was in the Jun 2017 quarter.
BIO's price to earnings ratio is currently 65% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Aug 12, 2025), Bio-Rad Laboratories's share price is $274.76. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $11.86. Therefore, Bio-Rad Laboratories's PE ratio for today is 23.17. PE RATIO(23.17) = STOCK PRICE($274.76) / TTM EPS($11.86)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.